Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population (TORCH)
THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
A PHASE4 clinical study on Symptomatic Aortic Stenosis, this trial is actively recruiting participants. The trial is conducted by Second Affiliated Hospital, School of Medicine, Zhejiang University and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Sep 2021 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Second Affiliated Hospital, School of Medicine, Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .